Developed with Olea Medical, the platform integrates data from QTscan, mammography, MRI, and ultrasound into a single interface.
QT Imaging Holdings, in collaboration with Olea Medical, has launched the QTI Imaging-Olea Viewer, a unified platform designed for viewing multiple breast imaging modalities. The system aims to help clinicians correlate findings from different imaging sources and monitor patients longitudinally.
According to a company release, the viewer is designed to streamline clinical workflow by reducing the need to use multiple software viewers. By consolidating images, the platform is intended to enhance clinical efficiency and support more informed patient management over time.
“Integrating quantitative, radiation-free QTscan data with mammography, digital breast tomosynthesis, MRI, and ultrasound in a single intuitive platform improves interpretive efficiency, strengthens diagnostic confidence, and supports a more multimodality approach to breast evaluation,” says Dr Bilal Malik, chief medical officer of QT Imaging, in a release.
Integrating Acoustic CT with Advanced Visualization
The viewer is optimized for QT Imaging’s Breast Acoustic CT system, which uses ultrasound tomography to generate true 3D volumetric breast images without ionizing radiation or compression. The company notes the technology offers particular clinical value for women with dense breast tissue by providing quantitative, reproducible imaging data.
Powered by Olea Medical’s visualization framework, the QT Imaging-Olea Viewer allows for analysis of QT Imaging datasets through 3D rendering and quantitative assessment. It is also designed to support future artificial intelligence and machine learning capabilities, including automated lesion segmentation and computer-aided detection applications.
“Our collaboration with QT Imaging shows how advanced software and imaging innovation can seamlessly come together to benefit clinicians and patients alike,” says Faycal Djeridane, Founder and CEO of Olea Medical, in a release. “By integrating QT Imaging’s quantitative biomarkers into our advanced imaging platform, we’re enabling a data-rich, cohesive viewing experience that enhances diagnostic efficiency.”
The QT Imaging-Olea Viewer was developed under a partnership between the two companies that was announced in January 2026.
Photo caption: QTI Imaging-Olea Viewer
Photo credit: QT Imaging
